|
NeoStem Forms Advisory Group of Experts for Steroid Resistant Asthma
GlobeNewswire (press release) NEW YORK, Sept. 9, 2013 (GLOBE NEWSWIRE) — NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, is pleased to announce that three experts at the forefront of asthma research have agreed to … NeoStem (NASDAQ: NBS) Forms Advisory Group for Steroid Resistant Asthma |
View full post on asthma – Google News